Tags

Type your tag names separated by a space and hit enter

[8.5/11.5F transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory hematospermia].
Zhonghua Nan Ke Xue. 2016 Mar; 22(3):225-8.ZN

Abstract

OBJECTIVE

To investigate the clinical application value of 8.5/11.5 F transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory hematospermia.

METHODS

We retrospectively analyzed 78 cases of refractory hematospermia diagnosed and treated by 8.5/11.5 F transurethral seminal vesiculoscopy from June 2012 to June 2014. The patients underwent serum PSA examination, transrectal ultrasonography, seminal vesicle ultrasonography, and pelvis CT or MRI before surgery, and all received transurethral seminal vesiculoscopy under the 8.5/11.5 F rigid ureteroscope.

RESULTS

Operations were all successfully accomplished, which revealed abnormal opening of the ejaculatory duct in 5 cases, mucosal inflammatory hyperemia in the prostatic utricle and seminal vesicle in 78, dark red mucilage substance in the seminal vesicle in 34, seminal vesicle stones in 19, small polyp in the seminal vesicle in 2, and ejaculatory duct or seminal vesicle cyst in 4. All the patients received symptomatic treatment during the surgery. After surgery, hematouria was found in 13 cases, which disappeared within 2 weeks, pelvic hematoma in 1 case, which was cured by conservative treatment within 3 months, and epididymitis in 2 cases, which was controlled by anti-infection treatment. Hematospermia recurred in 3 cases during the 1-year postoperative follow-up.

CONCLUSION

8.5/11.5 F transurethral seminal vesiculoscopy, with its advantages of easy operation, wide field of vision, large channel for operation, and few complications, deserves general clinical application in the diagnosis and treatment of refractory hematospermia.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

chi

PubMed ID

27172661

Citation

Zhu, Xiao-bo, et al. "[8.5/11.5F Transurethral Seminal Vesiculoscopy in the Diagnosis and Treatment of Refractory Hematospermia]." Zhonghua Nan Ke Xue = National Journal of Andrology, vol. 22, no. 3, 2016, pp. 225-8.
Zhu XB, Zhang XS, Zhang SL, et al. [8.5/11.5F transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory hematospermia]. Zhonghua Nan Ke Xue. 2016;22(3):225-8.
Zhu, X. B., Zhang, X. S., Zhang, S. L., Shi, H. L., Kong, C. H., Ding, D. G., & Liu, Z. H. (2016). [8.5/11.5F transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory hematospermia]. Zhonghua Nan Ke Xue = National Journal of Andrology, 22(3), 225-8.
Zhu XB, et al. [8.5/11.5F Transurethral Seminal Vesiculoscopy in the Diagnosis and Treatment of Refractory Hematospermia]. Zhonghua Nan Ke Xue. 2016;22(3):225-8. PubMed PMID: 27172661.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [8.5/11.5F transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory hematospermia]. AU - Zhu,Xiao-bo, AU - Zhang,Xiang-sheng, AU - Zhang,Shi-long, AU - Shi,Hong-lin, AU - Kong,Chao-hui, AU - Ding,De-gang, AU - Liu,Zhong-hua, PY - 2016/5/14/entrez PY - 2016/5/14/pubmed PY - 2016/6/11/medline SP - 225 EP - 8 JF - Zhonghua nan ke xue = National journal of andrology JO - Zhonghua Nan Ke Xue VL - 22 IS - 3 N2 - OBJECTIVE: To investigate the clinical application value of 8.5/11.5 F transurethral seminal vesiculoscopy in the diagnosis and treatment of refractory hematospermia. METHODS: We retrospectively analyzed 78 cases of refractory hematospermia diagnosed and treated by 8.5/11.5 F transurethral seminal vesiculoscopy from June 2012 to June 2014. The patients underwent serum PSA examination, transrectal ultrasonography, seminal vesicle ultrasonography, and pelvis CT or MRI before surgery, and all received transurethral seminal vesiculoscopy under the 8.5/11.5 F rigid ureteroscope. RESULTS: Operations were all successfully accomplished, which revealed abnormal opening of the ejaculatory duct in 5 cases, mucosal inflammatory hyperemia in the prostatic utricle and seminal vesicle in 78, dark red mucilage substance in the seminal vesicle in 34, seminal vesicle stones in 19, small polyp in the seminal vesicle in 2, and ejaculatory duct or seminal vesicle cyst in 4. All the patients received symptomatic treatment during the surgery. After surgery, hematouria was found in 13 cases, which disappeared within 2 weeks, pelvic hematoma in 1 case, which was cured by conservative treatment within 3 months, and epididymitis in 2 cases, which was controlled by anti-infection treatment. Hematospermia recurred in 3 cases during the 1-year postoperative follow-up. CONCLUSION: 8.5/11.5 F transurethral seminal vesiculoscopy, with its advantages of easy operation, wide field of vision, large channel for operation, and few complications, deserves general clinical application in the diagnosis and treatment of refractory hematospermia. SN - 1009-3591 UR - https://www.unboundmedicine.com/medline/citation/27172661/[8_5/11_5F_transurethral_seminal_vesiculoscopy_in_the_diagnosis_and_treatment_of_refractory_hematospermia]_ L2 - https://antibodies.cancer.gov/detail/CPTC-PSAT1-1 DB - PRIME DP - Unbound Medicine ER -